Form 4 holding
EVP, R&D and CSO
AbbVie Inc.
- Security class
- Common Stock, $0.01 par value
- Shares / value
- 52,376
- Estimated value
- $12,155,422
- Report date
- 27 Feb 2026
- Price
- $232.08
- Ownership
- Direct
Roopal Thakkar - EVP, R&D and CSO at AbbVie Inc.
Issuer-level insider activity
- Role
- EVP, R&D and CSO
- Issuer ticker
- ABBV on NYSE
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Roopal Thakkar since 21 Aug 2025
Reported holdings for Roopal Thakkar in AbbVie Inc.
Form 4 holding
EVP, R&D and CSO
AbbVie Inc.
- Security class
- Option (Right to buy)
- Shares / value
- 21,937
- Estimated value
- $2,337,500
- Report date
- 18 Feb 2026
- Price
- $93.50
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
EVP, R&D and CSO
AbbVie Inc.
- Security class
- Common Stock, $0.01 par value
- Shares / value
- 2,998
- Estimated value
- $669,333
- Report date
- 27 Feb 2026
- Price
- $223.26
- Ownership
- Profit sharing trust
Transaction history for Roopal Thakkar in AbbVie Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.